The strategy of optimizing and innovating customized pharmaceutical care results in pharmaceutical solutions and concepts that significantly improve patients' lives. Fagron spends circa 10% of turnover each year on Research & Development.

Fagron performs numerous scientific studies on a daily basis. Physical, chemical and microbiological stability studies are essential in the development of the Fagron vehicles and compounding formulations. Effectiveness studies give insights in the performance of the solutions that are developed and provided by Fagron.
This page provides an overview of our development pipeline. The content of our pipeline will change over time as new compounding concepts progress from discovery to development and from development to the market. This pipeline information was updated in December 2015. 

Visit the following links for more detailed information: